We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

96 hedge funds and large institutions have $571M invested in GenMark Diagnostics, Inc in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 99 → 96 (-3)

13% less capital invested

Capital invested by funds: $657M → $571M (-$85.9M)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
45
Reduced
18
Closed
16
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$59K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17M
2
CC
Casdin Capital
New York
+$8.47M
3
PI
Putnam Investments
Massachusetts
+$6.27M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.63M
5
PCM
Penn Capital Management
Pennsylvania
+$3.61M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$8.82M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.64M
3
Wells Fargo
Wells Fargo
California
-$2.65M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.38M
5
CRC
Curi RMB Capital
Illinois
-$2.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWA
76
TCI Wealth Advisors
Arizona
$66K -$2.06K -198 -3%
TRCT
77
Tower Research Capital (TRC)
New York
$65K +$70.3K +6,769 New
Victory Capital Management
78
Victory Capital Management
Texas
$62K – – –
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$52.5K -$3.44K -331 -6%
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$41K +$43.2K +4,162 +3,440%
EMG
81
ETF Managers Group
New Jersey
$40K +$3.82K +368 +10%
AIP
82
Ameritas Investment Partners
Nebraska
$36K – – –
IF
83
Ironwood Financial
Arizona
$34K – – –
UBS Group
84
UBS Group
Switzerland
$25K +$3.62K +348 +15%
AIS
85
AlphaOne Investment Services
Pennsylvania
$20K +$21.8K +2,100 New
Zurich Cantonal Bank
86
Zurich Cantonal Bank
Switzerland
$12K – – –
Barclays
87
Barclays
United Kingdom
$11K +$11.9K +1,148 +3,479%
CG
88
Cutler Group
California
$10K -$4.28K -412 -28%
GT
89
Glenmede Trust
Pennsylvania
$9K – – –
Bank of Montreal
90
Bank of Montreal
Ontario, Canada
$8K – – –
RWA
91
Ropes Wealth Advisors
Massachusetts
$6K +$6.58K +633 New
SSB
92
Sandy Spring Bank
Maryland
$4K – – –
SIM
93
Sonora Investment Management
Arizona
$3.85K – – –
NFG
94
Next Financial Group
Texas
$2K -$4.98K -479 -70%
Citigroup
95
Citigroup
New York
$2K +$499 +48 +43%
RE
96
RBC Europe
United Kingdom
$549 +$592 +57 New
Point72 Asset Management
97
Point72 Asset Management
Connecticut
– -$2.38M -201,000 Closed
MIM
98
Monashee Investment Management
Massachusetts
– -$1.48M -125,000 Closed
MS
99
Maven Securities
Jersey
– -$947K -80,000 Closed
Tudor Investment Corp
100
Tudor Investment Corp
Connecticut
– -$741K -62,652 Closed
1 2 3
4
5

GNMK Hedge Fund Activity: Q3 2017 in Review

96 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2017, worth a combined $571M — down 13% from $657M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GNMK and 13 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 45 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $17M. The largest seller was Citadel Advisors, cutting an estimated $8.82M.

  • 96 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2017, down from 99 in Q2 2017.
  • Funds reported $571M of GenMark Diagnostics, Inc stock for Q3 2017, down 13% quarter-over-quarter.
  • 13 funds opened new GenMark Diagnostics, Inc positions in Q3 2017 and 16 closed out, a net change of -3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2017 was T. Rowe Price Associates, an estimated $17M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2017 was Citadel Advisors, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2017.